How Smuckers earnings were unaffected by weight loss drugs

In This Article:

J.M. Smucker (SJM) stock rose Tuesday morning after the company posted better-than-expected results for its fiscal second quarter. Comparable sales for the company rose 7% in its second quarter compared to last year. Most notably, sales of the company’s "Uncrustables" line of products rose 22%.

J.M. Smucker CEO Mark Smucker joins Yahoo Finance to discuss earnings results, as well as the recent sentiment around weight loss drugs and their potential impact on consumer food sales for companies and brands like Smuckers.

"We haven't seen any meaningful impact at this point, of course, we are watching that very carefully. We are in the business to serve consumers, so we want to listen to them, to what they need," Smucker says. "If you think about our broader portfolio, we have products that will meet the needs of consumers across the entire value spectrum, but also in the snacking space. Consumers continue to snack more than they used to."

For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Video Transcript

SEANA SMITH:

(ON) SEANA SMITH: Mark, what's your assessment of the consumer? 'Cause there is a lot to be optimistic about obviously within your business, but I-- I would guess it's a very challenging time. How are you navigating what could be a tough couple of months?

MARK SMUCKER: You know, consumers, there are some consumers out there that are seeking value. Our portfolio, regardless of the category, whether it's coffee, pet snacks, handheld snacking, sweet baked snacks, all of those categories, we play in the entire spectrum of value. So value brands like Folgers all the way up to Dunkin' and Bustelo in the coffee space, even within milk bone our-- our pet snacks, there are both value and premium offerings, and so we're able to actually move and capture the consumer where they need to be and really want to make sure that we're meeting their needs. So even though there are some premium items that continue to grow, we are also seeing that-- that value consumer and capturing and providing them with products that they need as well.

BRAD SMITH: Uh, Mark i-- it seems like some of the weight loss drugs and the-- the trend there that we've seen of GLP 1s among consumers, too, that's presented a headwind for snacking as a whole, and we've heard that come up as a theme time after time again with some of the grocery retailers over the course of this earnings season. How is that kind of trickling through to your business? How is that kind of playing itself out? And even what your production looks like, the wholesale partnerships and where people are taking on inventory and that assessments that you have to think about on a day in, day out basis.